Determination of zafirlukast by stability indicating LC and derivative spectrophotometry
Authors:
- 14 August 2002
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 30 (3) , 695-703
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Validation of a LC method for the analysis of zafirlukast in a pharmaceutical formulationJournal of Pharmaceutical and Biomedical Analysis, 2000
- Comparison of Zafirlukast (Accolate®) Absorption After Oral and Colonic Administration in HumansPharmaceutical Research, 2000
- Leukotriene AntagonistsPulmonary Pharmacology & Therapeutics, 1998
- Zafirlukast: The First Leukotreene-Receptor Antagonist Approved for the Treatment of AsthmaAnnals of Pharmacotherapy, 1997
- Determination of zafirlukast, a selective leukotriene antagonist, human plasma by normal-phase high-performance liquid chromatography with fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- Quantitative Determination of Oxaprozin and Several of Its Related Compounds by High-Performance Reversed-Phase Liquid ChromatographyJournal of Liquid Chromatography, 1995
- Liquid chromatographic determination of the known low level impurities in lovastatin bulk drug: An application of high—low chromatographyTalanta, 1993
- Biomedical applications of derivative spectroscopyTrAC Trends in Analytical Chemistry, 1983
- Recent developments in pharmaceutical and clinical analysisAnalytical Proceedings including Analytical Communications, 1982
- Numerical error analysis of derivative spectrometry for the quantitative analysis of mixturesAnalytical Chemistry, 1976